TransMedics Group (TMDX) Misses Q1 EPS by 32c, provides guidance

TransMedics Group (NASDAQ: TMDX) reported Q1 EPS of $0.30, $0.32 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $173.9 million versus the consensus estimate of $174.47 million.

GUIDANCE:

TransMedics Group sees FY2026 revenue of $727-757 million, versus the consensus of $739 million.

For earnings history and earnings-related data on TransMedics Group (TMDX) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• EagleOne Metals closes $225,199 non-brokered private placement